Har-Shai Yaron, Sommer Adir, Gil Tamir, Krausz Judit, Gal-Or Nir, Mettanes Issa, Lavi Idit, Eyal Nir, Brizgalin Leonid, Taran Amir, Har-Shai Lior, Elmalach Irit
Unit of Plastic Surgery, Carmel Medical Center, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Israel Institute of Technology (Technion), Haifa, Israel.
Int J Dermatol. 2016 Mar;55(3):342-50. doi: 10.1111/ijd.13168. Epub 2016 Jan 8.
Incidences of basal cell carcinoma (BCC) on the lower extremities in elderly patients are rising. Surgical approaches to the treatment of BCC are subject to possible difficulties in healing, failure of skin grafts, and wound infection. This study assessed the efficacy of intralesional cryosurgery in the treatment of BCC of the lower limbs in elderly patients.
This study included eight patients aged >60 years in whom a total of 10 nodular or superficial BCCs of the lower limbs were confirmed by biopsy. The patients' medical histories revealed comorbidities including hypertension, diabetes, hypercholesterolemia, venous insufficiency, and deep vein thrombosis of the legs, congestive heart failure, chronic renal failure, and ischemic heart disease. Using liquid nitrogen, an intralesional cryosurgery needle (CryoShape) was inserted into the tumor to facilitate its complete freezing. Treatment success was confirmed by biopsy taken approximately 3 months after complete healing of the cryo-wound.
The average size of the lesions treated was 2.49 cm(2) (16.4 × 15.2 mm). Mean recovery time was 79.9 days. Biopsies were obtained at a mean of 85.3 days after the wound had healed. All 10 biopsies verified the complete destruction of the tumor. There was no evidence of wound infection or tumor recurrence over a follow-up period of 28 months.
This study demonstrates that a single intralesional cryosurgery session can completely eradicate BCC on the lower extremities in elderly patients. This technique is associated with relatively minor complications, is well tolerated, and represents a safe and effective therapeutic modality for BCC of the lower limbs.
老年患者下肢基底细胞癌(BCC)的发病率正在上升。BCC的手术治疗方法可能存在愈合困难、皮肤移植失败和伤口感染等问题。本研究评估了病灶内冷冻手术治疗老年患者下肢BCC的疗效。
本研究纳入了8例年龄>60岁的患者,经活检确诊共有10个下肢结节性或浅表性BCC。患者的病史显示存在合并症,包括高血压、糖尿病、高胆固醇血症、静脉功能不全、腿部深静脉血栓形成、充血性心力衰竭、慢性肾功能衰竭和缺血性心脏病。使用液氮,将病灶内冷冻手术针(CryoShape)插入肿瘤以使其完全冷冻。在冷冻伤口完全愈合后约3个月进行活检,以确认治疗成功。
治疗的病灶平均大小为2.49 cm²(16.4×15.2 mm)。平均恢复时间为79.9天。伤口愈合后平均85.3天进行活检。所有10次活检均证实肿瘤已完全破坏。在28个月的随访期内,没有伤口感染或肿瘤复发的证据。
本研究表明,单次病灶内冷冻手术可完全根除老年患者下肢的BCC。该技术相关并发症相对较少,耐受性良好,是下肢BCC的一种安全有效的治疗方式。